Coinfection with Hymenolepis nana, Hymenolepis diminuta, Giardia intestinalis, and Human Immunodeficiency Virus: A Case Report with Complex Immunologic Interactions

Am J Trop Med Hyg. 2017 May;96(5):1094-1096. doi: 10.4269/ajtmh.16-0413. Epub 2017 May 13.

Abstract

AbstractWe describe the case of a 43-year-old human immunodeficiency virus-infected man receiving combined antiretroviral therapy and coinfected with Hymenolepis nana, Hymenolepis diminuta, and Giardia intestinalis, presenting as chronic diarrhea and critical weight loss. Immunological aspects of these interactions are reviewed.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Animals
  • Anthelmintics / therapeutic use
  • Anti-HIV Agents / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Coinfection
  • Diarrhea / diagnosis*
  • Diarrhea / drug therapy
  • Diarrhea / parasitology
  • Diarrhea / virology
  • Giardia lamblia / drug effects
  • Giardia lamblia / growth & development
  • Giardiasis / diagnosis*
  • Giardiasis / drug therapy
  • Giardiasis / parasitology
  • HIV / drug effects
  • HIV / growth & development
  • HIV Infections / diagnosis*
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • Humans
  • Hymenolepiasis / diagnosis*
  • Hymenolepiasis / drug therapy
  • Hymenolepiasis / parasitology
  • Hymenolepis diminuta / drug effects
  • Hymenolepis diminuta / growth & development
  • Hymenolepis nana / drug effects
  • Hymenolepis nana / growth & development
  • Male
  • Metronidazole / analogs & derivatives
  • Metronidazole / therapeutic use
  • Nitro Compounds
  • Praziquantel / therapeutic use
  • Thiazoles / therapeutic use
  • Treatment Outcome
  • Weight Loss

Substances

  • Anthelmintics
  • Anti-HIV Agents
  • Antiprotozoal Agents
  • Nitro Compounds
  • Thiazoles
  • Metronidazole
  • Praziquantel
  • secnidazole
  • nitazoxanide